The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2013 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2013 AAPM Annual Meeting « Back

    113

    Perioperative Ketamine Reduces Post-Operative Opioid Consumption After Major Orthopedic Surgery in Patients with Fibromyalgia: A Retrospective Chart Review of 26 Cases

    Jonathan A. Day, MD, jonathan_day@yahoo.com1, Ramsha A. Kudia, BS1, Roy Greengrass, MD FRCP1, Bonnie L. Howe, RN BSN1, Steven B. Porter, MD1, Steve Clendenen, MD1, Ilana Logvinov RN MSN CCRP1, Beth Ladlie, MD MPH1, (1) Mayo Clinic, Jacksonville, Florida

    Introduction: Evidence is accumulating that use of low-dose ketamine may considerably reduce post-operative morphine consumption among patients on large dose opioids undergoing surgery. After anecdotal reports of improvement in fibromyalgia symptoms in fibromyalgia patients receiving ketamine, we conducted a retrospective study to provide a more systematic initial assessment of the potential impact of ketamine on fibromyalgia pain. With IRB approval, we conducted a retrospective chart review of 25 consecutive patients with fibromyalgia having total hip (n=10) or knee (n=15) arthroplasty all utilizing the same regional anesthetic blockade, except that 10 patients (5 hip, 5 knee) received low dose ketamine infusion, while the others did not. Our focus was on 48 hour post-operative oral morphine equivalent (ME) use. Data was analyzed using the stratified van Elteren test. 26 procedures of 25 patients (2 male, median age 60, range 28 to 82) met inclusion criteria from November 2009 to July 2011. Median 48 hour ME in patients without ketamine was 250mg, while the median with ketamine was 135mg. Despite the small sample size, this was marginally statistically significant with p=0.054, and consistent with the anecdotal reports. Fibromyalgia is a complicated disease process which despite modern treatment often leaves these patients in significant pain. The subsequent high use of narcotics further complicates their care. Low-dose ketamine, with its proven narcotic sparing effects, may provide a novel avenue of treatment for patients with fibromyalgia and more in depth prospective studies are warranted to investigate this further. References: 1) Loftus, R. et al. Intraoperative Ketamine Reduces Perioperative Opiate Consumption in Opiate-dependent Patients with Chronic Back Pain Undergoing Back Surgery. Anesthesiology 2010; 113: 639-646.

    Funding: None

    Figure:

    Poster 113

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In